{"@type":"dcat:Dataset","accessLevel":"public","bureauCode":["009:10"],"contactPoint":{"fn":"openFDA","hasEmail":"mailto:open@fda.hhs.gov"},"description":"<p>The CDRH Post-Approval Studies Program encompasses design, tracking, oversight, and review responsibilities for studies mandated as a condition of approval of a premarket approval (PMA) application, protocol development product (PDP) application, or humanitarian device exemption (HDE) application. The program helps ensure that well-designed post-approval studies (PAS) are conducted effectively and efficiently and in the least burdensome manner.</p>\n","distribution":[{"@type":"dcat:Distribution","downloadURL":"http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas_Excel.cfm","mediaType":"application/unknown","format":"unknown","title":"Unknown","identifier":"unknown-d26df93a-e63e-4725-9c42-9bc88ff34029","interra-published":true}],"identifier":"58457331-9ed5-4570-abc2-06e942a36956","keyword":["cdrh"],"language":["en"],"license":"http://opendefinition.org/licenses/odc-odbl/","modified":"2016-09-02","programCode":["009:005"],"publisher":{"@type":"org:Organization","name":"Department of Health &amp; Human Services"},"title":"Post-Approval Studies"}
